122 related articles for article (PubMed ID: 38555225)
1. Combination of DCE-MRI and NME-DWI via Deep Neural Network for Predicting Breast Cancer Molecular Subtypes.
Ba ZC; Zhang HX; Liu AY; Zhou XX; Liu L; Wang XY; Nanding A; Sang XQ; Kuai ZX
Clin Breast Cancer; 2024 Mar; ():. PubMed ID: 38555225
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Dynamic Contrast-Enhanced MRI and Non-Mono-Exponential Model-Based Diffusion-Weighted Imaging for the Prediction of Prognostic Biomarkers and Molecular Subtypes of Breast Cancer Based on Radiomics.
Zhang L; Zhou XX; Liu L; Liu AY; Zhao WJ; Zhang HX; Zhu YM; Kuai ZX
J Magn Reson Imaging; 2023 Nov; 58(5):1590-1602. PubMed ID: 36661350
[TBL] [Abstract][Full Text] [Related]
3. A Channel-Dimensional Feature-Reconstructed Deep Learning Model for Predicting Breast Cancer Molecular Subtypes on Overall b-Value Diffusion-Weighted MRI.
Zhou XX; Zhang L; Cui QX; Li H; Sang XQ; Zhang HX; Zhu YM; Kuai ZX
J Magn Reson Imaging; 2024 Apr; 59(4):1425-1435. PubMed ID: 37403945
[TBL] [Abstract][Full Text] [Related]
4. Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI.
Avendano D; Marino MA; Leithner D; Thakur S; Bernard-Davila B; Martinez DF; Helbich TH; Morris EA; Jochelson MS; Baltzer PAT; Clauser P; Kapetas P; Pinker K
Breast Cancer Res; 2019 Dec; 21(1):136. PubMed ID: 31801635
[TBL] [Abstract][Full Text] [Related]
5. Automated deep learning method for whole-breast segmentation in diffusion-weighted breast MRI.
Zhang L; Mohamed AA; Chai R; Guo Y; Zheng B; Wu S
J Magn Reson Imaging; 2020 Feb; 51(2):635-643. PubMed ID: 31301201
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of dynamic contrast enhancement and diffusion-weighted MRI for differentiation of benign from malignant non-mass enhancement breast lesions.
Zhang J; Li L; Zhang L; Zhe X; Tang M; Lei X; Zhang X
Front Oncol; 2024; 14():1332783. PubMed ID: 38544833
[TBL] [Abstract][Full Text] [Related]
7. Discrimination between HER2-overexpressing, -low-expressing, and -zero-expressing statuses in breast cancer using multiparametric MRI-based radiomics.
Zheng S; Yang Z; Du G; Zhang Y; Jiang C; Xu T; Li B; Wang D; Qiu Y; Lin D; Zhang X; Shen J
Eur Radiol; 2024 Feb; ():. PubMed ID: 38363315
[TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced magnetic resonance imaging features and apparent diffusion coefficient value of HER2-positive/HR-negative breast carcinoma.
Chen P; Zhao S; Guo W; Shao G
Quant Imaging Med Surg; 2023 Aug; 13(8):4816-4825. PubMed ID: 37581065
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.
Pinker K; Moy L; Sutton EJ; Mann RM; Weber M; Thakur SB; Jochelson MS; Bago-Horvath Z; Morris EA; Baltzer PA; Helbich TH
Invest Radiol; 2018 Oct; 53(10):587-595. PubMed ID: 29620604
[TBL] [Abstract][Full Text] [Related]
10. Characterization of breast cancer subtypes based on quantitative assessment of intratumoral heterogeneity using dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging.
Kim JJ; Kim JY; Suh HB; Hwangbo L; Lee NK; Kim S; Lee JW; Choo KS; Nam KJ; Kang T; Park H
Eur Radiol; 2022 Feb; 32(2):822-833. PubMed ID: 34345946
[TBL] [Abstract][Full Text] [Related]
11. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
12. Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.
Pinker K; Bogner W; Baltzer P; Gruber S; Bickel H; Brueck B; Trattnig S; Weber M; Dubsky P; Bago-Horvath Z; Bartsch R; Helbich TH
Invest Radiol; 2014 Jun; 49(6):421-30. PubMed ID: 24566292
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
[TBL] [Abstract][Full Text] [Related]
14. Multiparametric breast MRI with 3T: Effectivity of combination of contrast enhanced MRI, DWI and 1H single voxel spectroscopy in differentiation of Breast tumors.
Aribal E; Asadov R; Ramazan A; Ugurlu MÜ; Kaya H
Eur J Radiol; 2016 May; 85(5):979-86. PubMed ID: 27130059
[TBL] [Abstract][Full Text] [Related]
15. Predicting of axillary lymph node metastasis in invasive breast cancer using multiparametric MRI dataset based on CNN model.
Zhang X; Liu M; Ren W; Sun J; Wang K; Xi X; Zhang G
Front Oncol; 2022; 12():1069733. PubMed ID: 36561533
[TBL] [Abstract][Full Text] [Related]
16. Predicting cytogenetic risk in multiple myeloma using conventional whole-body MRI, spinal dynamic contrast-enhanced MRI, and spinal diffusion-weighted imaging.
Van Den Berghe T; Verberckmoes B; Kint N; Wallaert S; De Vos N; Algoet C; Behaeghe M; Dutoit J; Van Roy N; Vlummens P; Dendooven A; Van Dorpe J; Offner F; Verstraete K
Insights Imaging; 2024 Apr; 15(1):106. PubMed ID: 38597979
[TBL] [Abstract][Full Text] [Related]
17. Role of combined clinical-radiomics model based on contrast-enhanced MRI in predicting the malignancy of breast non-mass enhancements without an additional diffusion-weighted imaging sequence.
Li Y; Yang Z; Lv W; Qin Y; Tang C; Yan X; Yin T; Ai T; Xia L
Quant Imaging Med Surg; 2023 Sep; 13(9):5974-5985. PubMed ID: 37711822
[TBL] [Abstract][Full Text] [Related]
18. Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes.
Leithner D; Bernard-Davila B; Martinez DF; Horvat JV; Jochelson MS; Marino MA; Avendano D; Ochoa-Albiztegui RE; Sutton EJ; Morris EA; Thakur SB; Pinker K
Mol Imaging Biol; 2020 Apr; 22(2):453-461. PubMed ID: 31209778
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of DCE-MRI, multiparametric MRI and multimodality imaging for discrimination of breast non-mass-like enhancement lesions.
Zang H; Liu HL; Zhu LY; Wang X; Wei LM; Lou JJ; Zou QG; Wang SQ; Wang SJ; Jiang YN
Br J Radiol; 2022 Aug; 95(1136):20220211. PubMed ID: 35522775
[TBL] [Abstract][Full Text] [Related]
20. Application of MRI Image Based on Computer Semiautomatic Segmentation Algorithm in the Classification Prediction of Breast Cancer Histology.
Sheng A; Li A; Xia J; Ye Y
J Healthc Eng; 2021; 2021():6088322. PubMed ID: 34868525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
